Your browser doesn't support javascript.
loading
In vivo characterization of CYP2D6*12, *29 and *84 using dextromethorphan as a probe drug: a case report.
Gaedigk, Andrea; Twist, Greyson P; Farrow, Emily G; Lowry, Jennifer A; Soden, Sarah E; Miller, Neil A.
  • Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO 64108, USA.
  • Twist GP; School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA.
  • Farrow EG; Center for Pediatric Genomic Medicine, Children's Mercy Kansas City, Kansas City, MO 64108, USA.
  • Lowry JA; School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA.
  • Soden SE; Center for Pediatric Genomic Medicine, Children's Mercy Kansas City, Kansas City, MO 64108, USA.
  • Miller NA; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO 64108, USA.
Pharmacogenomics ; 18(5): 427-431, 2017 Apr.
Article en En | MEDLINE | ID: mdl-28290770
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Citocromo P-450 CYP2D6 / Dextrometorfano / Alelos Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Newborn Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Citocromo P-450 CYP2D6 / Dextrometorfano / Alelos Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Newborn Idioma: En Año: 2017 Tipo del documento: Article